We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases.
- Authors
Socinski, Mark A; Langer, Corey J; Huang, Jane E; Kolb, Margaret M; Compton, Peter; Wang, Lisa; Akerley, Wallace
- Abstract
Patients with non-small-cell lung cancer (NSCLC) and brain metastases have previously been excluded from trials of bevacizumab because of suspected risk of CNS hemorrhage. This phase II trial, AVF3752g (PASSPORT), specifically addressed bevacizumab safety (incidence of grade > or = 2 CNS hemorrhage) in patients with NSCLC and previously treated brain metastases.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 31, p5255
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2009.22.0616